BusinessAxim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)By Nasdaq OMXNov 21, 2017, 2:00 PM UTC
BusinessINC Research to Present at Upcoming Jefferies Global Healthcare ConferenceBy Nasdaq OMXMay 31, 2017, 8:33 PM UTC
BusinessINC Research to Present at Upcoming Jefferies Global Healthcare ConferenceBy Nasdaq OMXMay 31, 2017, 8:33 PM UTC
BusinessINC Research recognized by CSO Magazine for Second Consecutive Year for Innovative Employee Cyber Security Training ProgramBy Nasdaq OMXMay 4, 2017, 7:46 PM UTC
BusinessINC Research Receives 2016 Frost & Sullivan Asia Pacific Contract Research Outsourcing Services Customer Value Leadership AwardBy Nasdaq OMXOct 24, 2016, 12:33 PM UTC
BusinessINC Research Receives 2016 Frost & Sullivan Asia Pacific Contract Research Outsourcing Services Customer Value Leadership AwardBy Nasdaq OMXOct 24, 2016, 12:33 PM UTC
BusinessINC Research Receives 2016 Frost & Sullivan Asia Pacific Contract Research Outsourcing Services Customer Value Leadership AwardBy Nasdaq OMXOct 24, 2016, 12:33 PM UTC
BusinessINC Research Receives 2016 Frost & Sullivan Asia Pacific Contract Research Outsourcing Services Customer Value Leadership AwardBy Nasdaq OMXOct 24, 2016, 12:33 PM UTC
